Lixisenatide
- CAS No.
- 320367-13-3
- Chemical Name:
- Lixisenatide
- Synonyms
- Lyxumia;lixisenatide;Lixisenatide, >98%;Lixisenatide Acetate;Lixisenatide USP/EP/BP;Lixisenatide|Lixisenatide Acetate
- CBNumber:
- CB01518519
- Molecular Formula:
- C215H347N61O65S
- Molecular Weight:
- 4858.53
- MOL File:
- 320367-13-3.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/7/2 8:54:57
storage temp. | Store at -20°C |
---|---|
solubility | Water:103.0(Max Conc. mg/mL);21.2(Max Conc. mM) |
form | Solid |
color | White to pink |
Sequence | H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys-NH2 |
InChIKey | XVVOERDUTLJJHN-JXBMKTOPNA-N |
CAS DataBase Reference | 320367-13-3 |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS08,GHS05 |
---|---|
Signal word | Danger |
Hazard statements | H318-H361 |
Precautionary statements | P201-P202-P281-P308+P313-P405-P501-P280-P305+P351+P338-P310 |
Lixisenatide Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 137)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
Wuhan Fortuna Chemical Co., Ltd | +86-027-59207850 | China | 5999 | 58 | Inquiry |
Apextide Co Ltd | +86-15300650552 +86-15300650552 | China | 71 | 58 | Inquiry |
Zibo Hangyu Biotechnology Development Co., Ltd | +86-0533-2185556 +8617865335152 | China | 11027 | 58 | Inquiry |
Nantong Guangyuan Chemicl Co,Ltd | +undefined17712220823 | China | 616 | 58 | Inquiry |
Shanghai Getian Industrial Co., LTD | +86-15373193816 +86-15373193816 | China | 274 | 58 | Inquiry |
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | China | 32760 | 60 | Inquiry |
career henan chemical co | +86-0371-86658258 +8613203830695 | China | 29901 | 58 | Inquiry |
Shenzhen Nexconn Pharmatechs Ltd | +86-755-89396905 +86-15013857715 | China | 10259 | 58 | Inquiry |
BOC Sciences | +1-631-485-4226 | United States | 19553 | 58 | Inquiry |
Related articles
- Lixisenatide: pharmacodynamics, pharmacokinetics and clinical applications
- Lixisenatide, a GLP-1 receptor agonist, improves glycemic control, promotes weight loss, and has cardioprotective properties i....
- Nov 15,2023
- Application of Lixisenatide
- Lixisenatide (Adlyxin, Sanofi-Aventis) is the newest FDA-approved GLP-1RA and obtained approval on July 27, 2016.
- Dec 13,2021
320367-13-3(Lixisenatide)Related Search:
lixisenatide
Lixisenatide|Lixisenatide Acetate
Lixisenatide Acetate
Lixisenatide, >98%
Lixisenatide USP/EP/BP
Lyxumia
320367-13-3
C215H347N61O65S